Leclercia adecarboxylata bacteremia in a patient with long-term use of nonsteroidal anti-inflammatory drugs

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Leclercia adecarboxylata, a ubiquitous Gram-negative bacillus, is generally viewed as an opportunistic pathogen because it is rarely cultured from clinical samples. Although rare, bacteremia due to L. adecarboxylata tends to occur in immunocompromised hosts and patients with systemic comorbidities. Only one case of bacteremia due to L. adecarboxylata has been reported in a previously healthy patient. We describe a male patient with an active peptic ulcer who developed L. adecarboxylata bacteremia after a long-term use of nonsteroidal anti-inflammatory drugs. The abdomen is believed to have been the most probable portal of entry. After appropriate medical management, the patient recovered without sequela.

Original languageEnglish
Pages (from-to)452-454
JournalJournal of Microbiology, Immunology and Infection
Volume49
Issue number3
DOIs
Publication statusPublished - Jun 1 2016

Fingerprint

Enterobacteriaceae
Bacteremia
Anti-Inflammatory Agents
Immunocompromised Host
Pharmaceutical Preparations
Peptic Ulcer
Abdomen
Bacillus
Comorbidity

Keywords

  • Bacteremia
  • Immunocompetent
  • Leclercia adecarboxylata
  • Nonsteroidal anti-inflammatory drugs
  • Peptic ulcer

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases
  • Immunology and Allergy
  • Immunology and Microbiology(all)

Cite this

@article{9ebb349afb7e49da9bcc85d0b1708db8,
title = "Leclercia adecarboxylata bacteremia in a patient with long-term use of nonsteroidal anti-inflammatory drugs",
abstract = "Leclercia adecarboxylata, a ubiquitous Gram-negative bacillus, is generally viewed as an opportunistic pathogen because it is rarely cultured from clinical samples. Although rare, bacteremia due to L. adecarboxylata tends to occur in immunocompromised hosts and patients with systemic comorbidities. Only one case of bacteremia due to L. adecarboxylata has been reported in a previously healthy patient. We describe a male patient with an active peptic ulcer who developed L. adecarboxylata bacteremia after a long-term use of nonsteroidal anti-inflammatory drugs. The abdomen is believed to have been the most probable portal of entry. After appropriate medical management, the patient recovered without sequela.",
keywords = "Bacteremia, Immunocompetent, Leclercia adecarboxylata, Nonsteroidal anti-inflammatory drugs, Peptic ulcer",
author = "ShioShin Jean and Wen-Sen Lee and Kuan-Jen Bai and Carlos Lam and Chin-Wung Hsu and Ray-Jade Chen and Hsueh, {Po Ren}",
year = "2016",
month = "6",
day = "1",
doi = "10.1016/j.jmii.2013.09.004",
language = "English",
volume = "49",
pages = "452--454",
journal = "Journal of Microbiology, Immunology and Infection",
issn = "0253-2662",
publisher = "Elsevier Taiwan LLC",
number = "3",

}

TY - JOUR

T1 - Leclercia adecarboxylata bacteremia in a patient with long-term use of nonsteroidal anti-inflammatory drugs

AU - Jean, ShioShin

AU - Lee, Wen-Sen

AU - Bai, Kuan-Jen

AU - Lam, Carlos

AU - Hsu, Chin-Wung

AU - Chen, Ray-Jade

AU - Hsueh, Po Ren

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Leclercia adecarboxylata, a ubiquitous Gram-negative bacillus, is generally viewed as an opportunistic pathogen because it is rarely cultured from clinical samples. Although rare, bacteremia due to L. adecarboxylata tends to occur in immunocompromised hosts and patients with systemic comorbidities. Only one case of bacteremia due to L. adecarboxylata has been reported in a previously healthy patient. We describe a male patient with an active peptic ulcer who developed L. adecarboxylata bacteremia after a long-term use of nonsteroidal anti-inflammatory drugs. The abdomen is believed to have been the most probable portal of entry. After appropriate medical management, the patient recovered without sequela.

AB - Leclercia adecarboxylata, a ubiquitous Gram-negative bacillus, is generally viewed as an opportunistic pathogen because it is rarely cultured from clinical samples. Although rare, bacteremia due to L. adecarboxylata tends to occur in immunocompromised hosts and patients with systemic comorbidities. Only one case of bacteremia due to L. adecarboxylata has been reported in a previously healthy patient. We describe a male patient with an active peptic ulcer who developed L. adecarboxylata bacteremia after a long-term use of nonsteroidal anti-inflammatory drugs. The abdomen is believed to have been the most probable portal of entry. After appropriate medical management, the patient recovered without sequela.

KW - Bacteremia

KW - Immunocompetent

KW - Leclercia adecarboxylata

KW - Nonsteroidal anti-inflammatory drugs

KW - Peptic ulcer

UR - http://www.scopus.com/inward/record.url?scp=84886409689&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886409689&partnerID=8YFLogxK

U2 - 10.1016/j.jmii.2013.09.004

DO - 10.1016/j.jmii.2013.09.004

M3 - Article

VL - 49

SP - 452

EP - 454

JO - Journal of Microbiology, Immunology and Infection

JF - Journal of Microbiology, Immunology and Infection

SN - 0253-2662

IS - 3

ER -